192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: A dosimetric point of view

Radiotherapy and Oncology

Volumn 78, Issue 1, 2006, Pages 47-52

  Nickers, Philippe ^a   Thissen, Benedicte ^a   Jansen, Nicolas ^a   Deneufbourg, J M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

125I; 192Ir; Brachytherapy; Dosimetry; Prostate; Selectivity

Indexed keywords

IODINE 125; IRIDIUM 192; IRIDIUM; RADIOACTIVE IODINE;

ARTICLE; BRACHYTHERAPY; CANCER RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; PELVIC GIRDLE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; ADENOCARCINOMA; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROSTATE TUMOR; RADIATION RESPONSE;

ADENOCARCINOMA; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; IRIDIUM RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 31144449060     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.09.002     Document Type: Article

References (23)

1. D.G. Brachman, T. Thomas, J. Hilbe, and D.C. Beyer Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumours in 2222 patients: results from a single practice Int J Radiat Oncol Biol Phys 48 2000 111 117
2. C. Charra-Brunaud, I.C. Hsu, V. Weinberg, and J. Pouliot Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high- dose-rate brachytherapy using a computer model Int J Radiat Oncol Biol Phys 56 2003 586 591
3. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer J Am Med Assoc 280 1998 969 974
4. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma Int J Radiat Oncol Biol Phys 35 1996 875 879
5. A. Dosoretz, R. Stock, J. Cesaretti, and N. Stone Role of external beam radiation and hormonal therapy in low, intermediate, and high risk patients treated with permanent radioactive seed implantation Int J Radiat Oncol Biol Phys 57 S 2003 227
6. A. Dutreix, and G. Marinello The paris system B. Pierquin J.F. Wilson D. Chassagne Modern brachytherapy 1987 Masson publishing USA Paris, France 25 42
7. J.F. Fowler, R.J. Chappell, and M.A. Ritter Is α/β for prostate tumors really low ? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
8. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90
9. R.M. Galalae, A. Martinez, and T. Mate Long-term outcome by risk factors using conformal high dose rate (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055
10. D.Y. Gelblum, L. Potters, R. Ashley, R. Waldbaum, X.H. Wang, and S. Leibel Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 1999 59 67
11. P.D. Grimm, J.C. Blasko, and H. Ragde Ultrasound guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early-stage prostate cancer: technical concepts in planning, operative technique, and evaluation P.F. Schellhammer New techniques in prostatic surgery 1995 Saunders Philadelphia 113 126
12. ICRU REPORT 38. Dose and volume specification for reporting intracavitary therapy in gynecology; 1985.
13. G. Kovacs, R. Potter, and T. Loch GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer Radiother Oncol 74 2005 137 148
14. W.R. Lee, J. Moughan, J. Owen, and M. Zelefsky The 1999 patterns of care survey of radiation therapy in localized prostate cancer. A comprehensive survey of prostate brachytherapy in the United States Int J Radiat Oncol Biol Phys 57 Suppl. 2 2003 226
15. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
16. A.A. Martinez, G. Gustafson, and J. Gonzalez Dose escalation using conformal high dose rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 2002 316 327
17. G.S. Merrick, W.M. Butler, R.W. Galbreath, and J.H. Lief Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer Int J Radiat Oncol Biol Phys 51 2001 41 48
18. S. Nag, D. Beyer, J. Friedland, P. Grimm, and R. Nath American brachytherapy society recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
19. P. Nickers, L. Coppens, M. Beauduin, M. Darimont, J. de Leval, and J.M. Deneufbourg Feasibility study combining low dose rate 192 Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma Radiother Oncol 55 2000 41 47
20. P. Nickers, E. Lenaerts, B. Thissen, and J.M. Deneufbourg Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system ? Radiother Oncol 74 2005 131 136
21. J.E. Sylvester, J.C. Blasko, P.D. Grimm, R. Meier, and J.A. Malmgren Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience Int J Radiat Oncol Biol Phys 57 2003 944 952
22. M.D. Terk, R.G. Stock, and N.N. Stone Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1998 1379 1382
23. J.Z. Wang, and X.A. Li Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose Med Phys 30 2003 34 40